Abeona Therapeutics Inc (ABEO)
4.40
-0.20
(-4.35%)
USD |
NASDAQ |
May 17, 16:00
4.42
+0.02
(+0.45%)
After-Hours: 20:00
Abeona Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.0209 |
| March 31, 2021 | 0.0186 |
| December 31, 2020 | 0.0171 |
| September 30, 2020 | 0.0153 |
| June 30, 2020 | 0.0145 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.0831 |
| September 30, 2014 | -0.0082 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.0594 |
| June 30, 2012 | -0.0885 |
| March 31, 2012 | -0.1364 |
| December 31, 2011 | -0.1562 |
| September 30, 2011 | -0.2344 |
| June 30, 2011 | -0.2298 |
| March 31, 2011 | -0.2422 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.0209
Maximum
Jun 2021
0.0051
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| T2 Biosystems Inc | -1.103 |
| INVO Bioscience Inc | 3.096 |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.5683 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 74.83M |
| Total Liabilities (Quarterly) | 83.71M |
| Shareholders Equity (Quarterly) | -8.881M |